openPR Logo
Press release

Leading Growth Driver in the Nuclear Medicine Diagnostics Market in 2025: Surging Demand For Nuclear Medicine Diagnostics Drives Market Expansion Worldwide Driver's Influence

03-12-2025 06:11 AM CET | Health & Medicine

Press release from: The Business Research Company

Nuclear Medicine Diagnostics

Nuclear Medicine Diagnostics

What industry-specific factors are fueling the growth of the nuclear medicine diagnostics market?
The growth of the nuclear medicine diagnostics market is anticipated to surge forward due to the rising demand for nuclear medicine diagnostics. Nuclear medicine, which uses radioactive substances within the human body to diagnose diseases and to target and eliminate unhealthy organs or tissues, primarily serves diagnostic purposes in radiation and other treatments with high mortality risks. The increasing utility of nuclear medicine diagnostics could be attributed to their accuracy and their aid in the decision-making process for treatments. For instance, the World Nuclear Association, a UK-based international organization advocating for nuclear power, published a report in April 2022 stating that the annual count of nuclear medicine treatments exceeds 40 million, and the requirement for radioisotopes increases by up to 5% annually. Furthermore, over 10,000 hospitals globally carry out 90% of all medical procedures involving radioisotopes. Therefore, the rising demand for nuclear medicine diagnostics is likely to stimulate the expansion of the nuclear medicine diagnostics market.

Get Your Nuclear Medicine Diagnostics Market Report Here:
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

What growth opportunities are expected to drive the nuclear medicine diagnostics market's CAGR through 2034?
The market size for nuclear medicine diagnostics has witnessed a significant surge in recent times. The market is projected to expand from a worth of $7.16 billion in 2024 and attain a value of $7.94 billion by 2025, showing a compound annual growth rate (CAGR) of 11.0%. Factors that have spurred growth in this historic period include technological advancements in medical imaging, a rise in the incidence of chronic illnesses, an aging demographic, application in cancer treatment, and the precision and accuracy in diagnostics.

The market size of nuclear medicine diagnostics is anticipated to experience significant expansion in the coming years, reaching $12.56 billion in 2029 with a compound annual growth rate (CAGR) of 12.1%. This predicted growth during the forecast period can be linked to the broadening applications in the field of neurology, integration with various imaging modalities, approaches focusing on precision medicine, the increasing demand for theranostics, and worldwide efforts to eradicate disease. Key trends expected within the forecast period encompass a move towards decentralized, small-scale radiopharmacy, the use of nuclear medicine in neurology, radiomics, and quantitative imaging analysis, partnerships for research and development, and a focus on radiation safety and dosimetry.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9415&type=smp

What new trends are reshaping the nuclear medicine diagnostics market and its opportunities?
Leading entities in the nuclear medicine diagnostics market are striving to offer innovative solutions like advanced medical technologies to establish themselves competitively. These progressive medical technologies represent the height of innovation in the medical field, aimed at improving patient outcomes, elevating care standards and fostering improved health. For instance, Gleneagles Hospital, based in Malaysia, unveiled its Nuclear Medicine Unit in August 2023. This unit, part of the hospital's specialized facilities, is equipped with the state-of-the-art technology and a team of highly trained professionals. Designed for early detection, diagnosis, and treatment of diseases, this unit utilizes nuclear medicine imaging techniques.

What major market segments define the scope and growth of the nuclear medicine diagnostics market?
The nuclear medicine diagnostics market covered in this report is segmented -

1) By Type: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
2) By Application: Cardiology, Thyroid, Neurology, Oncology, Other Applications
3) By End-User: Hospitals And Diagnostic Centers, Research Institutes

Subsegments:
1) By SPECT Radiopharmaceuticals: Technetium-99m-Based Radiopharmaceuticals, Iodine-123-Based Radiopharmaceuticals, Thallium-201-Based Radiopharmaceuticals, Other SPECT Radiopharmaceuticals
2) By PET Radiopharmaceuticals: Fluorine-18-Based Radiopharmaceuticals, Carbon-11-Based Radiopharmaceuticals, Gallium-68-Based Radiopharmaceuticals, Other PET Radiopharmaceuticals

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9415

Which region dominates the nuclear medicine diagnostics market?
North America was the largest region in the nuclear medicine diagnostics market in 2024. The regions covered in the nuclear medicine diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the nuclear medicine diagnostics industry growth?
Major companies operating in the nuclear medicine diagnostics market include Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., Mallinckrodt Pharmaceuticals, Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, Curium SAS, Cardinal Health Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, Telix Pharmaceuticals Limited, Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC, Navidea Biopharmaceuticals Inc., Cyclopharm Limited, Isologic Innovative Radiopharmaceuticals, Clarity Pharmaceuticals Limited, Actinium Pharmaceuticals Inc., Jubilant DraxImage Inc., PharmaLogic Holdings Corp, Institute of Isotopes Co Ltd., Global Medical Solutions LLC, Theragnostics Ltd., Eczacibasi-Monrol Nuclear Products Co.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=9415&type=smp

What Is Covered In The Nuclear Medicine Diagnostics Global Market Report?

•Market Size Forecast: Examine the nuclear medicine diagnostics market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the nuclear medicine diagnostics market for a structured understanding.
•Key Players Overview: Analyze major players in the nuclear medicine diagnostics market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the nuclear medicine diagnostics market.
•Segment Contributions: Evaluate how different segments drive overall growth in the nuclear medicine diagnostics market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the nuclear medicine diagnostics market.
•Industry Challenges: Identify potential risks and obstacles affecting the nuclear medicine diagnostics market.
•Competitive Landscape: Review strategic developments in the nuclear medicine diagnostics market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leading Growth Driver in the Nuclear Medicine Diagnostics Market in 2025: Surging Demand For Nuclear Medicine Diagnostics Drives Market Expansion Worldwide Driver's Influence here

News-ID: 3911142 • Views:

More Releases from The Business Research Company

2025-2034 Inkjet Coder Market Evolution: Disruptions, Innovations, and Untapped Opportunities
2025-2034 Inkjet Coder Market Evolution: Disruptions, Innovations, and Untapped …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Inkjet Coder Market Through 2025? Strong growth has been witnessed in recent years in the inkjet coder market. It is projected that this market will expand from $2.11 billion in 2024 to $2.27 billion in 2025, experiencing a compound annual growth rate
Global Industrial Cooking Fire Protection Systems For Food Manufacturing Market Projected to Grow at 5.4% CAGR, Reaching $3.43 Billion by 2029
Global Industrial Cooking Fire Protection Systems For Food Manufacturing Market …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Industrial Cooking Fire Protection Systems For Food Manufacturing Industry Market Size Be by 2025? Over the past few years, the market size for industrial cooking fire protection systems used in food manufacturing has seen a consistent growth. It is projected that the market value will grow
High Speed Engine Market Trends That Will Shape the Next Decade: Insights from Innovative Turbogenerator Technology In High-Speed Engine Applications
High Speed Engine Market Trends That Will Shape the Next Decade: Insights from I …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the High Speed Engine Market Size By 2025? The market for high speed engines has seen considerable growth in the last few years. The market which is valued at $24.17 billion in 2024 is predicted to reach $25.58 billion in 2025, experiencing a Compound Annual Growth
Industrial Sector Growth Fuels Expansion Of Evaporative Cooling Market: The Driving Engine Behind Evaporative Cooling Market Evolution in 2025
Industrial Sector Growth Fuels Expansion Of Evaporative Cooling Market: The Driv …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Evaporative Cooling Market Size Growth Forecast: What to Expect by 2025? The market size for evaporative cooling has seen a robust growth in recent times. The outlook predicts an escalation from $6.41 billion in 2024 to $6.8 billion in 2025, with a compound annual growth rate (CAGR) of 6.0%.

All 5 Releases


More Releases for Radiopharma

Nuclear Pharmacy Market Future Business Opportunities 2025-2032 | Curium Pharma, …
The Latest study titled Nuclear Pharmacy Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive research delves into the evolving market dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. Additionally, the report
Actinium Pharmaceuticals (ATNM) Garners Attention with Clinical Successes and St …
Actinium's Chief Medical Officer, said, "In addition to demonstrating unprecedented 100% access to BMT in Iomab-B treated patients with active r/r AML and achieving the primary endpoint of dCR with high statistical significance, we are excited by the compelling outcomes in patients with a TP53 mutation in the SIERRA trial. We look forward to returning to EBMT and once again highlighting the positive results from the Phase 3 SIERRA trial
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma A …
Biotech Stocks Taking Centerstage As the pharmaceutical industry ventures deeper into the era of precision medicine, radiopharmaceuticals, particularly those involving alpha emitters like Actinium-225 (Ac-225), are gaining prominence for their targeted approach to cancer treatment. Amid this innovative surge, Actinium Pharmaceuticals (NYSE:ATNM) emerges not just as a company with a promising pipeline but as a beacon of cutting-edge manufacturing capabilities that could very well position it as a prime buyout candidate
2030 Projections: Radiopharmaceutical Synthesizers Market to Deliver Dynamic Pro …
The Radiopharmaceutical Synthesizers Market Research Report 2023-2030 provides in-depth information on market trends, market capacity, industry size, growth factors, share, innovations, competitive environment, business problems, and more. This report's historical data confirms demand growth on a global, national, and regional scale. The studies on the global industry cover everything from comprehensive research to market size and forecasting to dynamics, growth factors, prospects, and hazards, as well as vendor knowledge. The
Automated Radiosynthesis Modules Market Strategic Assessment & SWOT Analysis 202 …
An Informative report titled as Global Automated Radiosynthesis Modules Market has recently been published by Report Consultant to its online repository. This statistical data offers an in-depth analysis by considering several segments, such as type, size, technology and applications. Different exploratory techniques such as, qualitative and quantitative analysis have been used to give data accurately. For better understanding of the customers, it uses effective graphical presentation techniques, such as graphs,
Cyclotron Market Growth Opportunities Analysis Report | GE Healthcare, Siemens H …
Cyclotron Market: Introduction According to the report, the global cyclotron market was valued at US$ 215.5 Mn in 2019. It is projected to expand at a CAGR of ~3% from 2020 to 2030. Expansion activities of key radiopharma players; applications in clinical trials; increase in the geriatric population; pipeline assessment of new drugs; and disease indication mortality are major factors driving the cyclotron market. The shutdown of a few nuclear reactors has led to the